
Irbesartan tablets
Form: Tablets
Strength: 75 mg, 150 mg, 300 mg
Reference Brands: Avapro(Us & EU)
Category: Hypertension
Irbesartan tablets, marketed as Avapro, are approved in the US by the FDA and in the EU via EMA for hypertension and diabetic nephropathy. Regulatory approval requires a detailed dossier, including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews comprehensive clinical trial and quality information, while the EMA verifies compliance with regional safety, efficacy, and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring regional compliance supports timely approval, safe medication use, and global availability of irbesartan tablets, helping manage hypertension and protect renal function worldwide effectively.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Antithymocyte Globulin (ATG) powder for injection
Strength: 250mg/5ml
Form: Lyophilized powder
Reference Brands: Thymoglobulin(US & EU)
View Details Get EnquiryHydralazine tablets
Strength: 10 mg, 25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Apresoline(US & Eu)
View Details Get EnquiryMethyldopa tablets
Strength: 250 mg, 500 mg, and 750 mg
Form: Tablets
Reference Brands: Aldomet(US)
View Details Get EnquiryClonidine Patch
Strength: 0.1 mg/24 hours, 0.2 mg/24 hours, 0.3 mg/24 hours
Form: transdermal patch
Reference Brands: Catapres(US)
View Details Get Enquiry